T-cell responses following Natural Influenza Infection or Vaccination in Solid Organ Transplant Recipients

[1]  Deepali Kumar,et al.  Cell-Mediated Immune Responses after Influenza Vaccination of Solid Organ Transplant Recipients: a Secondary Outcomes Analysis of a Randomized Controlled Trial. , 2019, The Journal of infectious diseases.

[2]  A. Limaye,et al.  A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Deepali Kumar,et al.  A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Shile Huang,et al.  Host Immune Response to Influenza A Virus Infection , 2018, Front. Immunol..

[5]  M. Savic,et al.  Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy , 2017, PloS one.

[6]  J. Yewdell,et al.  Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge. , 2016, The Journal of infectious diseases.

[7]  S. Riley,et al.  Longevity and determinants of protective humoral immunity after pandemic influenza infection. , 2015, American journal of respiratory and critical care medicine.

[8]  G. Rimmelzwaan,et al.  Virus-specific T cells as correlate of (cross-)protective immunity against influenza. , 2015, Vaccine.

[9]  A. Bousvaros,et al.  2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. McVernon,et al.  Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides , 2013, Nature Communications.

[11]  William W Kwok,et al.  CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination. , 2013, International immunology.

[12]  R. González-Amaro,et al.  Influenza Virus Infection but Not H1N1 Influenza Virus Immunization Is Associated with Changes in Peripheral Blood NK Cell Subset Levels , 2013, Clinical and Vaccine Immunology.

[13]  Deepali Kumar,et al.  Randomized Controlled Trial of High‐Dose Intradermal Versus Standard‐Dose Intramuscular Influenza Vaccine in Organ Transplant Recipients , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  B. Gärtner,et al.  CD4+ T‐cell immunity after pandemic influenza vaccination cross‐reacts with seasonal antigens and functionally differs from active influenza infection , 2012, European journal of immunology.

[15]  Deborah M. Brown,et al.  Multifunctional CD4 Cells Expressing Gamma Interferon and Perforin Mediate Protection against Lethal Influenza Virus Infection , 2012, Journal of Virology.

[16]  Deepali Kumar,et al.  Long Term Immune Responses to Pandemic Influenza A/H1N1 Infection in Solid Organ Transplant Recipients , 2011, PloS one.

[17]  M. Ison,et al.  Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations † , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  G. Lyon,et al.  Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. , 2010, The Lancet. Infectious diseases.

[19]  L. Chatenoud,et al.  Humoral and Cellular Immune Responses after Influenza Vaccination in Kidney Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  P. Andersen,et al.  Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells1 , 2009, The Journal of Immunology.

[21]  C. Ewen,et al.  Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. , 2009, Vaccine.

[22]  John Sidney,et al.  Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans , 2008, Journal of Virology.

[23]  M. Roederer,et al.  T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.

[24]  A. Osterhaus,et al.  Influenza Vaccination Is Efficacious and Safe in Renal Transplant Recipients , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[26]  H. Robinson,et al.  Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing Cells , 2007, Journal of Virology.

[27]  C. Ewen,et al.  T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly1 , 2006, The Journal of Immunology.

[28]  P. Doherty,et al.  Cell-mediated Protection in Influenza Infection , 2006, Emerging infectious diseases.

[29]  R. Cox,et al.  Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines , 2004, Scandinavian journal of immunology.